Serum Prostate-Specific Antigen Profile Following Radiotherapy for Prostate Cancer: Implications for Patterns of Failure and Definition of Cure
- 1 April 1998
- Vol. 51 (4) , 566-572
- https://doi.org/10.1016/s0090-4295(97)00650-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinomaCancer, 1997
- Prostate cancer and radiation therapy—The message conveyed by serum prostate-specific antigenInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Routine prostate biopsies following radiotherapy for prostate cancer: Results for 226 patientsUrology, 1995
- Control of Prostate Cancer with Radiotherapy: Long-Term ResultsJournal of Urology, 1994
- PSA confirmation of cure at 10 years of T1B, T2, N0, M0 prostate cancer patients treated in RTOG protocol 7706 with external beam irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Radical Radiation Therapy in the Management of Prostatic Adenocarcinoma: The Initial Prostate Specific Antigen Value as a Predictor of Treatment OutcomeJournal of Urology, 1994
- Prostate-specific antigen kinetics after external beam irradiation for carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Prostate Specific Antigen after External Beam Radiotherapy for Prostatic Cancer: FollowupJournal of Urology, 1993
- Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostatesCancer, 1989